Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)
Hussin A. Rothan, Teow Chong Teoh
Molecular Biotechnology (2021) Vol. 63, Iss. 3, pp. 240-248
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 173
Recent advances in drug repurposing using machine learning
Fabio Urbina, Ana C. Puhl, Sean Ekins
Current Opinion in Chemical Biology (2021) Vol. 65, pp. 74-84
Open Access | Times Cited: 46
Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 19
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
Agnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 797-797
Open Access | Times Cited: 6
HTSplotter: An end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening
Carolina Nunes, Jasper Anckaert, Fanny De Vloed, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296322-e0296322
Open Access | Times Cited: 5
Tea Catechins in Green Tea Inhibit the Activity of SARS-CoV-2 Main Protease via Covalent Adduction
Yoji Kato, Sakiko Suzuki, Akari Higashiyama, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
Kuang‐Yu Chen, Tim Krischuns, Laura Ortega Varga, et al.
Antiviral Research (2022) Vol. 201, pp. 105272-105272
Open Access | Times Cited: 20
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2
Emery Smith, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 3, pp. 95-101
Open Access | Times Cited: 10
Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor
Gustavo Fernando Mercaldi, Eduardo Henrique Salviano Bezerra, Fernanda Aparecida Heleno Batista, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
Yoji Kato, Akari Higashiyama, Emi Takaoka, et al.
Advances in Redox Research (2021) Vol. 3, pp. 100021-100021
Open Access | Times Cited: 15
Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases
Anoop Narayanan, Shay A. Toner, Joyce Jose
Biochemical Society Transactions (2021) Vol. 50, Iss. 1, pp. 151-165
Closed Access | Times Cited: 15
Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro
Santiago Matías Ruatta, Denis N. Prada Gori, Martín Fló, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
Cyrille Mathieu, Franck Touret, Clémence Jacquemin, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1814-1814
Open Access | Times Cited: 13
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors
Ana C. Puhl, Melina Mottin, Carolina Q. Sacramento, et al.
ACS Omega (2022) Vol. 7, Iss. 32, pp. 27950-27958
Open Access | Times Cited: 9
Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold
Nefeli Theodora Tsilimingkra, Christos Papaneophytou
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 15, pp. 1343-1358
Closed Access | Times Cited: 1
Discovery of novel thioquinazoline-N-aryl-acetamide/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: Synthesis, in vitro biological evaluation, and molecular docking studies
Heba T. Abdel‐Mohsen, Mohamed A. Omar, Omnia Kutkat, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134690-134690
Open Access | Times Cited: 8
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
Denis N. Prada Gori, Santiago Matías Ruatta, Martín Fló, et al.
Frontiers in Drug Discovery (2023) Vol. 2
Open Access | Times Cited: 4
Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
Aurélie Deroubaix, Anna Kramvis
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 5
A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene
Yu-Jia Shi, Jiaqi Li, Hongqing Zhang, et al.
Virologica Sinica (2023) Vol. 38, Iss. 4, pp. 585-594
Open Access | Times Cited: 2
Synthesis, in silico and in vitro studies of novel quinazolinone derivatives as potential SARS-CoV-2 3CLpro inhibitors
Mubarak A. Alamri, Obaid Afzal, Md Jawaid Akhtar, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 1, pp. 105384-105384
Open Access | Times Cited: 2
Tripartite Split‐GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2‐E3 Ubiquitination Enzymes
Cécile Polge, Stéphanie Cabantous, Daniel Taillandier
ChemBioChem (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 2
Development of a cell-based DIFF-rGFP assay system for generalized discovery of viral protease Inhibitors
Xiaoyan Wu, Feng Yan, Rui-ting Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Yeast-Based Screening of Anti-Viral Molecules
Vartika Srivastava, Ravinder Kumar, Aijaz Ahmad
Microorganisms (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access
An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease
Sunniva Sigurdardóttir, Suélen Fernandes Silva, Ievgeniia Tiukova, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access
Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
Lalehan Oktay, Ece Erdemoğlu, Ilayda Tolu, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 459-468
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top